This FOA invites applications for projects designed to test the effectiveness of microphysiological systems (MPS), also called “tissue chip,” technology, for clinical trial frameworks by demonstrating their applied use in clinical trial planning and execution, addressing both safety and efficacy in late-stage preclinical studies. This approach is to provide evidence of the utility of tissue chip technology for precision medicine in informing trial design, establishing recruitment criteria and stratification of patient populations in identifying the best responders to candidate therapeutics.
- Letter of Intent Due Date(s): September 9, 2019
- Application Due Date(s): October 9, 2019
RFA-TR-19-014 Expiration Date October 10, 2019